Literature DB >> 30284905

Colorectal cancer screening and survival.

José Díaz-Tasende1.   

Abstract

It is difficult to resist the undeniable allure of screening as a means to diagnose common, potentially serious diseases before their natural history reaches an incurable stage. Colorectal cancer (CRC) is a classical example where the benefits seem to be within reach: we have technologies available that allow its diagnosis before symptoms or signs develop, at a reasonable cost, and using methods acceptable by a significant percentage of the population.

Entities:  

Mesh：

Year:  2018        PMID： 30284905     DOI： 10.17235/reed.2018.5870/2018

Source DB:  PubMed          Journal:  Rev Esp Enferm Dig        ISSN： 1130-0108            Impact factor:   2.086


  7 in total

Review 1.  A New Comorbidity in Periodontitis: Fusobacterium nucleatum and Colorectal Cancer.

Authors:  Francisco Mesa; Maria José Mesa-López; Juan Egea-Valenzuela; Cristina Benavides-Reyes; Luigi Nibali; Mark Ide; Giuseppe Mainas; Manfredi Rizzo; Antonio Magan-Fernandez
Journal:  Medicina (Kaunas)       Date:  2022-04-15       Impact factor: 2.948

Review 2.  Granzymes-Their Role in Colorectal Cancer.

Authors:  Sara Pączek; Marta Łukaszewicz-Zając; Barbara Mroczko
Journal:  Int J Mol Sci       Date:  2022-05-09       Impact factor: 6.208

3.  LINC01006 and miR-3199 Serve as Novel Markers of Poor Prognosis in Colon Cancer and Regulate Cell Proliferation, Migration and Invasion.

Authors:  Yaoqiang Wu; Bo Yu; Yaping Li; Fuxiang Yu; Zhongguo Li; Daxin Chen; Feng Jiang; Jianbo Bo; Hongwei Xue; Hongyang Lv; Haiyang Li
Journal:  Int J Gen Med       Date:  2022-02-16

4.  Circular RNAs as Diagnostic and Prognostic Indicators of Colorectal Cancer: A Pooled Analysis of Individual Studies.

Authors:  Cong Long; Qiu-Bo Xu; Li Ding; Li-Juan Huang; Yong Ji
Journal:  Pathol Oncol Res       Date:  2022-03-17       Impact factor: 3.201

5.  Propofol Prevents the Growth, Migration, Invasion, and Glycolysis of Colorectal Cancer Cells by Downregulating Lactate Dehydrogenase Both In Vitro and In Vivo.

Authors:  Zhichao Wu; Han Wang; Zu-An Shi; Yalan Li
Journal:  J Oncol       Date:  2022-04-30       Impact factor: 4.501

6.  Elevated CEA and CA 19-9 Levels within the Normal Ranges Increase the Likelihood of CRC Recurrence in the Chinese Han Population.

Authors:  Lujia Wang; Guangkai Zhang; Jiafeng Shen; Yujiang Shen; Guojun Cai
Journal:  Appl Bionics Biomech       Date:  2022-09-22       Impact factor: 1.664

7.  Identification of biomarkers for the diagnosis and treatment of primary colorectal cancer based on microarray technology.

Authors:  Zhi Gang Zheng; Bao Qing Ma; Yu Xiao; Tian Xi Wang; Tian Yu; Yu Hu Huo; Qing Qing Wang; Meng Jie Shan; Ling Bing Meng; Jing Han
Journal:  Transl Cancer Res       Date:  2020-05       Impact factor: 1.241
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.